Navigation Links
Iomai to Announce Fourth Quarter and Year-End 2007 Financial Results and Host Webcast on Thursday, March 6
Date:3/3/2008

GAITHERSBURG, Md., March 3 /PRNewswire-FirstCall/ -- Iomai Corporation (Nasdaq: IOMI) today announced that it will release fourth quarter and year-end 2007 financial results before the markets open and hold a conference call and live webcast to discuss corporate and clinical progress on Thursday, March 6, 2008 at 1:30 p.m. Eastern Time.

Conference Call Details

To access the live conference call on Thursday, March 6 at 1:30 p.m. Eastern Time via phone, please dial 866-578-5784 from the United States and Canada or +1-617-213-8056 internationally. The conference ID is 87233725. Please dial in approximately 10 minutes prior to the start of the call. A telephone replay will be available beginning approximately one hour after the call through March 10 and may be accessed by dialing 888-286-8010 from the United States and Canada or +1-617-801-6888 internationally. The replay passcode is 74369365.

To access the live and subsequently archived webcast of the conference call, go to the Investor Relations section of the Company's website at http://www.iomai.com. Please connect to the web site at least 15 minutes prior to the call to allow for any software download that may be necessary. The webcast is also being distributed through the Thomson StreetEvents Network. Individual investors can listen to the call at http://www.earnings.com, Thomson's individual investor portal, powered by StreetEvents. Institutional investors can access the call via Thomson StreetEvents (http://www.streetevents.com), a password-protected event management site.

About Iomai Corporation

'/>"/>
SOURCE Iomai Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Iomai CEO to Speak at BIO CEO & Investor Forum on Feb. 12
2. Iomai to Announce Third Quarter 2007 Financial Results and Host Webcast on Tuesday, November 13
3. Iomai Chief Scientific Officer Dr. Gregory Glenn Details Development of Travelers Diarrhea Patch at Keystone Conference
4. Iomai CEO to Speak at Natixis Bleichroeder Hidden Gems Conference on Monday
5. Rosetta Genomics Announces Allowance of Two Additional microRNA Patents
6. ROBODOC(R) Announces Patent Cross Licensing Agreement With IBM
7. MiMedx Announces Brian J. Splan as President
8. Boston Scientific Announces European Approval of New Heart Failure Lead
9. WaferGen Announces Management Team Promotions
10. Renovo Announces Results of Latest Phase 2 Studies of JUVISTA(R) (Human Recombinant TGFbeta3)
11. AEterna Zentaris and Paladin Labs Announce Sale and Purchase of Miltefosine Rights

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009).... 3 VIA Pharmaceuticals,...cused on the development of compounds for the trea...ay announced that it has completed the last patien...IA-2291. ,, The FDG-PET trial enrolled 52 pati...nd Canada including Massachusetts General Hospital...
(Date:12/3/2009)...HI, India, Dec. 3 /PRNewswire-Asia/ -- Dr. Susan J...en Beike Biotechnology Co. Ltd.,( http://www.beike... Diabetic,Foot Care in New Delhi, India, November ...rch and regenerative medicine company. , ...ssociation (IPA), aimed,to help podiatrists and re...
(Date:12/2/2009).... 2 Reportlinker.com announces tha... catalogue: ,, Drug Discovery Technologies - A...s ,, http://www.reportlinker.com/p0164246/Dru...et-Trends--Opportunities.html ,, Drug discover...ery pharmaceutical company,s business strategy. Th...
(Date:12/2/2009)...bon, December 2 , - "Bols...and Heritage" , Coinciding with the Inter...abonese Republic is hosting an international confe...arding biological resources in Africa. The,confere...rs, ministers,scientific experts, private compani...
Breaking Biology Technology:VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 3VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 4Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9Libreville International Conference 2-3 June 2010 2
...ise Recovery and Stress Management, Supports Natur...NSWICK, N.J., May 13 WellGen, Inc., a life scienc...icals, today announced the launch of its first con...under the brand name Te Ame. The Te Ame(TM) line ...ulations, reflecting WellGen,s research into a ran...
... privately held developer of novel therapies for a...kin disorders, today announced that William D. Ju,...ecutive officer. Dr. Ju succeeds Daphne Zohar, ma...ounding CEO of Follica. Dr. Ju will join existing...aab, former CEO, Genentech, president and COO, Abb...
...y 13 Poniard Pharmaceuticals, Inc. (Nasdaq: PAR...tive oncology therapies, today announced that Jerr...icer, will provide a corporate overview at the Lee...sday, May 20, at 2:00 p.m. Eastern Time in New Yor...l include a discussion about the clinical developm...
Other Biology Technology:WellGen, Inc. Launches Te Ame(TM) Nutritional Supplements With Proven Health Benefits of Proprietary Black Tea Extract 2WellGen, Inc. Launches Te Ame(TM) Nutritional Supplements With Proven Health Benefits of Proprietary Black Tea Extract 3Follica Appoints Drug Development and Dermatology Veteran, William D. Ju, as Chief Executive Officer 2Follica Appoints Drug Development and Dermatology Veteran, William D. Ju, as Chief Executive Officer 3Follica Appoints Drug Development and Dermatology Veteran, William D. Ju, as Chief Executive Officer 4Poniard Pharmaceuticals to Present at the Leerink Swann Oncology Roundtable Conference 2
(Date:12/2/2009)... , , Researchers from the University of Georgia C...cted" dual discovery that could open new avenues f..., a devastating single-celled protozoan parasite t... aid of whole-genome sequencing, researchers found...llular bacteria: Bacteroides, which are usually f...
(Date:12/2/2009)... , DURHAM, N.C. Duke University Medical Center r...malignant brain cancer glioma may be better able t...ock a particular signaling pathway in these cancer...ma cells with radiation in a laboratory experiment...showed that cancer stem cells resist the effects o...
(Date:12/2/2009)... , , It turns out that wearing a cap is good for ...chers from the Johns Hopkins Engineering in Oncolo...led "cap" of thread-like fibers holds the cell,s n...e. Understanding this cap,s influence on cell and ...clues to the diagnosis and treatment of diseases s...
Breaking Biology News(10 mins):UGA researchers lead team in discovery involving devastating freshwater fish parasite, 'Ich' 2UGA researchers lead team in discovery involving devastating freshwater fish parasite, 'Ich' 3Discovery makes brain tumor cells more responsive to radiation 2A cell's 'cap' of bundled fibers could yield clues to disease 2Insurance Commissioner Says Federal Health Care Reform Necessary to Fix a Broken System 56405 1Insurance Commissioner Says Federal Health Care Reform Necessary to Fix a Broken System 56405 2IMRIS receives FDA clearance for IMRISNV and IMRIScardio 56403 1IMRIS receives FDA clearance for IMRISNV and IMRIScardio 56403 2Fall 2009 Sees Spike in Enrollments at CDI College 56402 1Fall 2009 Sees Spike in Enrollments at CDI College 56402 2
...nisms behind latent cell memory, which can come to... suddenly to appear. Special yeast cells for examp... to hermaphrodite. , Researchers from the Niels ...e used mathematical models and computer simulation.... The research is an interdisciplinary cooperation...
...eir children have peanut allergies every year, man...y, a study by researchers at the University of New... has found. , Peanut allergies occur in one in 200... Clinical Immunology and Allergy. , "This is a ..., a Sydney Children,s Hospital immunologist and MD...
...Barcelona (UAB), in cooperation with the CSIC, hav... detects the presence, in food, of very small amou...cides in agriculture and which also has very long ...ibiotics in food. The biosensor is faster, more po...methods which are used to detect contaminants, whi...
Other Biology News:Latent memory of cells comes to life 2Latent memory of cells comes to life 3Peanut allergies overstated, study finds 2A new portable biosensor detects traces of contaminants in food more quickly and cheaply 2
Rabbit Anti-GluR2 Polyclonal Antibody, Unconjugated from Novus Biologicals
E. coli Protein Sample, lyophilized, 2.7 mg from Bio-Rad
... The Partec Cell Counter Analyser counts cells bas...e CCA detects only cells, so that other non cellul...passing through a 250 m square quartz cuvette each...sed as a counting signal and information about the...
... Conjugated peptides, recombinant or native protei...veloped an immunization protocol optimized in time...s obtained. We recommend the use of 2 animals per ... average serum yield on a 77-day protocol is appro...
Biology Products: